Lisi Zeng

机构：Harbin Medical University

发表论文 5 篇 · 总被引 21 次 · h-index 3

代表论文

• Successful Treatment of Hurthle Cell Thyroid Carcinoma with Lung and Liver Metastasis Using Docetaxel and Cisplatin (2012 · Japanese Journal of Clinical Oncology · 被引 10)
• KLX ameliorates liver cancer progression by mediating ZBP1 transcription and ubiquitination and increasing ZBP1-induced PANoptosis (2025 · Acta Pharmacologica Sinica · 被引 5)
• Zinc finger BED-type containing 6 (ZBED6) ameliorates cardiac fibrosis by inhibiting Piezo1 transcription and YAP nuclear translocation (2026 · Acta Pharmacologica Sinica · 被引 3)
• Paclitaxel hyperthermia suppresses gastric cancer migration through MiR-183-5p/PPP2CA/AKT/GSK3β/β-catenin axis (2024 · Journal of Cancer Research and Clinical Oncology · 被引 2)
• 667P Furmonertinib 160mg as first-line treatment for metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastases (2024 · Annals of Oncology · 被引 1)